{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:45:26Z","timestamp":1791906326770,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.amjoto.2021.103126","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:14:54Z","timestamp":1624518894000},"page":"103126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review"],"prefix":"10.1016","volume":"42","author":[{"given":"Ortiz H.","family":"Enrique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchez H.","family":"Eloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trujillo P.","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Villamor","family":"Perla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjoto.2021.103126_bb0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.otc.2019.03.011","article-title":"Update on recurrent respiratory papillomatosis","volume":"52","author":"Derkay","year":"2019","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.amjoto.2021.103126_bb0010","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archotol.129.9.976","article-title":"National registry for juvenile-onset recurrent respiratory papillomatosis","volume":"129","author":"Reeves","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103126_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fped.2019.00383","article-title":"Airway papillomatosis: New treatments for an old challenge","volume":"7","author":"Kumar","year":"2019","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.amjoto.2021.103126_bb0020","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lary.26450","article-title":"Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child","volume":"127","author":"Zur","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjoto.2021.103126_bb0025","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3892\/ol.2014.2486","article-title":"Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis","volume":"8","author":"Mohr","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.amjoto.2021.103126_bb0030","doi-asserted-by":"crossref","first-page":"110352","DOI":"10.1016\/j.ijporl.2020.110352","article-title":"Systemic bevacizumab for recurrent respiratory papillomatosis","volume":"138","author":"Baday","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.amjoto.2021.103126_bb0035","first-page":"e72","article-title":"Tracheobronchial and pulmonary papillomatosis without involvement of the larynx treated with intravenous bevacizumab in a child","volume":"117","author":"Cuestas","year":"2019","journal-title":"Arch Argent Pediatr"},{"issue":"6","key":"10.1016\/j.amjoto.2021.103126_bb0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MOO.0b013e328316930e","article-title":"Recurrent respiratory papillomatosis: update 2008","volume":"16","author":"Gallagher","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103126_bb0045","doi-asserted-by":"crossref","first-page":"109762","DOI":"10.1016\/j.ijporl.2019.109762","article-title":"Bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in an infant","volume":"129","author":"Gates","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2021.103126_bb0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/TCRM.S81825","article-title":"Recurrent respiratory papillo- matosis: current and future perspectives","volume":"11","author":"Carifi","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.amjoto.2021.103126_bb0055","doi-asserted-by":"crossref","first-page":"109706","DOI":"10.1016\/j.ijporl.2019.109706","article-title":"Systemic bevacizumab for end-stage juvenile recurrent respiratory papillomas: a case report","volume":"128","author":"Hamdi","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.amjoto.2021.103126_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/jamaoto.2013.1810","article-title":"Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children","volume":"139","author":"Rogers","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2021.103126_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000348940511400407","article-title":"Role of vascular endothelial growth factor-a in recurrent respiratory papillomatosis","volume":"114","author":"Rahbar","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"4","key":"10.1016\/j.amjoto.2021.103126_bb0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/lary.27674","article-title":"Safe use of systemic bevacizumab for respiratory recurrent papillomatosis in two children","volume":"129","author":"Carnevale","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjoto.2021.103126_bb0075","first-page":"1","article-title":"Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to en- hance 532-nm pulsed KTP laser treatment of glottal papillomatosis","volume":"201","author":"Zeitels","year":"2009","journal-title":"Ann Otol Rhi- nol Laryngol Suppl"},{"issue":"10","key":"10.1016\/j.amjoto.2021.103126_bb0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/000348941112001001","article-title":"Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papilloma- tosis of the vocal folds: a prospective study","volume":"120","author":"Zeitels","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:08:07Z","timestamp":1759295287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070921002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0196070921002271"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103126","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103126"}}